Figure 2From: Failure of combined antiretroviral therapy intensification with maraviroc and raltegravir in chronically HIV-1 infected patients to reduce the viral reservoir: the IntensHIV randomized trialEvolution in the 2 arms of immune markers over 48 weeks. 2a: CD4+ T cells. 2b: CD8+ T cells. 3c: CD8+CD38+ T cells. Arm 1: intensified. Arm 2: controls. Results are shown as means with 95% confidence intervals (bars). * paired t-test: p = 0.01 compared to baseline. ♯ unpaired t-test: p = 0.002 compared to baseline.Back to article page